https://www.sciencedaily.com/news/health_medicine/pain_control/ Pain Management and Pain Control. Read about causes of aches and pains and breaking news on conventional and alternative pain control methods. en-us Mon, 20 Apr 2026 02:48:56 EDT Mon, 20 Apr 2026 02:48:56 EDT 60 https://www.sciencedaily.com/images/scidaily-logo-rss.png https://www.sciencedaily.com/news/health_medicine/pain_control/ For more science news, visit ScienceDaily. https://www.sciencedaily.com/releases/2026/04/260415043617.htm A massive, nearly 20-year study tracking over 650,000 Americans with irritable bowel syndrome is raising new questions about the long-term safety of common treatments. Researchers found that some widely used medications—including antidepressants and certain antidiarrheal drugs—were linked to a small but noticeable increase in the risk of death over time. Thu, 16 Apr 2026 05:19:45 EDT https://www.sciencedaily.com/releases/2026/04/260415043617.htm https://www.sciencedaily.com/releases/2026/04/260413043129.htm New research reveals that obesity affects men and women in surprisingly different ways. Men are more likely to develop harmful abdominal fat and signs of liver stress, while women show higher inflammation and cholesterol levels. These differences could help explain why health risks vary between sexes. Scientists say this could lead to more tailored treatments for obesity. Mon, 13 Apr 2026 09:29:20 EDT https://www.sciencedaily.com/releases/2026/04/260413043129.htm https://www.sciencedaily.com/releases/2026/04/260411022029.htm A new study reveals that popular diabetes and weight-loss drugs like Ozempic and Wegovy may not work as effectively for about 10% of people due to specific genetic variants. These individuals appear to have a puzzling condition called “GLP-1 resistance,” where their bodies produce higher levels of the hormone targeted by these drugs—but don’t respond to it properly. Sun, 12 Apr 2026 08:58:54 EDT https://www.sciencedaily.com/releases/2026/04/260411022029.htm https://www.sciencedaily.com/releases/2026/04/260408225950.htm Chronic inflammation often works quietly in the background but can fuel serious diseases like diabetes, heart disease, and cancer. New research reveals that everyday plant compounds—like menthol from mint, cineole from eucalyptus, and capsaicin from chili peppers—can team up inside immune cells to dramatically boost their anti-inflammatory power. While individual compounds showed modest effects, certain combinations amplified results hundreds of times over by activating different cellular pathways at once. Thu, 09 Apr 2026 02:57:22 EDT https://www.sciencedaily.com/releases/2026/04/260408225950.htm https://www.sciencedaily.com/releases/2026/04/260402042751.htm A new clinical trial suggests that what people eat could finally offer real relief for Crohn’s disease, a condition that has long lacked clear dietary guidance. Researchers found that a “fasting-mimicking diet” — involving just five days a month of very low-calorie, plant-based meals — led to noticeable improvements in symptoms for most participants. Even more striking, the diet didn’t just make patients feel better; it also reduced key biological markers of inflammation linked to the disease. Fri, 03 Apr 2026 04:55:54 EDT https://www.sciencedaily.com/releases/2026/04/260402042751.htm https://www.sciencedaily.com/releases/2026/03/260326075559.htm Having both excess belly fat and low muscle mass isn’t just unhealthy—it’s potentially deadly, raising the risk of death by 83%. This condition, called sarcopenic obesity, creates a vicious cycle where fat accelerates muscle breakdown and inflammation. Researchers found it can be identified using simple measurements, not costly medical tests. That means earlier detection—and a real chance to intervene before serious decline sets in. Fri, 27 Mar 2026 01:23:23 EDT https://www.sciencedaily.com/releases/2026/03/260326075559.htm https://www.sciencedaily.com/releases/2026/03/260326075550.htm Scientists have uncovered a hidden reason why cancer treatments don’t work equally well for everyone. Certain drugs can become trapped inside lysosomes within tumor cells, forming slow-release reservoirs that create uneven drug distribution. This means some cancer cells are heavily exposed while others are barely affected. Understanding this process could help doctors better tailor treatments and improve outcomes. Fri, 27 Mar 2026 08:31:17 EDT https://www.sciencedaily.com/releases/2026/03/260326075550.htm https://www.sciencedaily.com/releases/2026/03/260319044648.htm Stopping popular weight-loss injections like Ozempic or Mounjaro might not trigger the dramatic rebound many fear. A large real-world study of nearly 8,000 patients found that most people who discontinue these drugs manage to keep the weight off—or even continue losing—by restarting treatment, switching medications, or adopting lifestyle changes. While earlier clinical trials suggested rapid weight regain, this new evidence paints a more hopeful picture. Thu, 19 Mar 2026 23:08:04 EDT https://www.sciencedaily.com/releases/2026/03/260319044648.htm https://www.sciencedaily.com/releases/2026/03/260313055130.htm A severe case of COVID-19 or influenza could increase the risk of lung cancer later on, according to new research. Scientists discovered that serious viral infections can alter immune cells in the lungs, leaving behind chronic inflammation that may help tumors develop months or years later. The increased risk was seen mainly after severe infections that required hospitalization. Vaccination, however, appears to prevent the dangerous lung changes. Fri, 13 Mar 2026 05:56:17 EDT https://www.sciencedaily.com/releases/2026/03/260313055130.htm https://www.sciencedaily.com/releases/2026/02/260225081159.htm Popular acid reflux drugs such as Prilosec, Nexium, and Protonix may carry hidden risks when taken long term. A new study found that extended use disrupted iron and calcium levels in rats, changes associated with anemia and osteoporosis risk. Researchers also observed shifts in mineral balance across multiple organs. Experts say the medications are effective, but prolonged use without medical guidance could have unintended consequences. Thu, 26 Feb 2026 07:27:39 EST https://www.sciencedaily.com/releases/2026/02/260225081159.htm https://www.sciencedaily.com/releases/2026/02/260221000328.htm Flea and tick medications trusted by pet owners worldwide may have an unexpected environmental cost. Scientists found that active ingredients from isoxazoline treatments pass into pet feces, exposing dung-feeding insects to toxic chemicals. These insects are essential for nutrient cycling and soil health. The findings suggest everyday pet treatments could ripple through ecosystems in surprising ways. Sun, 22 Feb 2026 01:24:32 EST https://www.sciencedaily.com/releases/2026/02/260221000328.htm https://www.sciencedaily.com/releases/2026/02/260219040816.htm A new human study has uncovered how the body naturally turns off inflammation. Researchers found that fat-derived molecules called epoxy-oxylipins rein in immune cells that can otherwise drive chronic disease. Using a drug to boost these molecules reduced pain faster and lowered harmful inflammatory cells. The discovery could pave the way for safer treatments for arthritis, heart disease, and other inflammation-related conditions. Thu, 19 Feb 2026 10:16:55 EST https://www.sciencedaily.com/releases/2026/02/260219040816.htm https://www.sciencedaily.com/releases/2026/02/260217005759.htm A major new study has spotlighted three familiar medicines that could take on an unexpected new role in the fight against Alzheimer’s disease — with a shingles vaccine emerging as the front-runner. After reviewing 80 existing drugs, an international panel of experts identified Zostavax, Viagra (sildenafil), and riluzole as the most promising candidates for repurposing. Wed, 18 Feb 2026 07:02:28 EST https://www.sciencedaily.com/releases/2026/02/260217005759.htm https://www.sciencedaily.com/releases/2026/02/260211204204.htm A new clinical trial suggests that changing when you eat could make a meaningful difference for people living with Crohn’s disease. Researchers found that time-restricted feeding, a form of intermittent fasting that limits meals to an 8-hour daily window, reduced disease activity by 40% and cut abdominal discomfort in half over 12 weeks. Participants also lost weight and showed healthier inflammation and immune markers, even though they did not reduce calories or change what they ate. Wed, 11 Feb 2026 21:25:28 EST https://www.sciencedaily.com/releases/2026/02/260211204204.htm https://www.sciencedaily.com/releases/2026/02/260211073033.htm Three major reviews commissioned by the World Health Organization find that GLP-1 drugs including tirzepatide (sold as Mounjaro and Zepbound), semaglutide (Ozempic and Wegovy), and liraglutide (Victoza and Saxenda) can lead to substantial weight loss in people with obesity. But while the results are impressive, researchers caution that most trials were funded by drugmakers, long term safety data are still limited, and side effects such as nausea are common. Wed, 11 Feb 2026 10:01:13 EST https://www.sciencedaily.com/releases/2026/02/260211073033.htm https://www.sciencedaily.com/releases/2026/02/260209064254.htm Scientists have discovered why ovarian cancer spreads so rapidly through the abdomen. Cancer cells enlist normally protective abdominal cells, forming mixed groups that work together to invade new tissue. These helper cells lead the way, allowing cancer to spread faster and resist chemotherapy. The findings uncover a critical weakness that future treatments may target. Mon, 09 Feb 2026 06:51:03 EST https://www.sciencedaily.com/releases/2026/02/260209064254.htm https://www.sciencedaily.com/releases/2026/02/260203030551.htm Popular weight-loss drugs like Ozempic and Wegovy can dramatically curb appetite, but experts warn many users are flying blind when it comes to nutrition. New research suggests people taking these medications may not be getting enough guidance on protein, vitamins, and overall diet quality, increasing the risk of muscle loss and nutrient deficiencies. Wed, 04 Feb 2026 10:43:08 EST https://www.sciencedaily.com/releases/2026/02/260203030551.htm https://www.sciencedaily.com/releases/2026/01/260131082433.htm Lowering salt in everyday foods could quietly save lives. Researchers found that modest sodium reductions in bread, packaged foods, and takeout meals could significantly reduce heart disease and stroke rates in France and the U.K. The key advantage is that people would not need to alter their eating habits at all. Small changes to the food supply could deliver large, long-term health benefits. Sat, 31 Jan 2026 09:27:42 EST https://www.sciencedaily.com/releases/2026/01/260131082433.htm https://www.sciencedaily.com/releases/2026/01/260129080428.htm A fast-aging fish is giving scientists a rare, accelerated look at how kidneys grow old—and how a common drug may slow that process down. Researchers found that SGLT2 inhibitors, widely used to treat diabetes and heart disease, preserved kidney structure, blood vessels, and energy production as the fish aged, while also calming inflammation. The results help explain why these drugs protect kidneys and hearts so reliably in people, even beyond blood sugar control. Fri, 30 Jan 2026 07:31:31 EST https://www.sciencedaily.com/releases/2026/01/260129080428.htm https://www.sciencedaily.com/releases/2026/01/260128075359.htm Ozempic, Mounjaro, and Zepbound can drive impressive weight loss, but stopping them is often followed by rapid weight regain. Researchers found that people regain weight faster after quitting these drugs than after diet and exercise alone. Improvements in heart health and diabetes risk also tend to reverse within a few years. The results suggest long-term success may require more than medication alone. Wed, 28 Jan 2026 07:53:59 EST https://www.sciencedaily.com/releases/2026/01/260128075359.htm https://www.sciencedaily.com/releases/2026/01/260120000323.htm Ibuprofen may be doing more than easing aches and pains—it could also help reduce the risk of some cancers. Studies have linked regular use to lower rates of endometrial and bowel cancer, likely because the drug dampens inflammation that fuels tumor growth. Researchers have even found it can interfere with genes cancer cells rely on to survive. Still, experts warn that long-term use carries risks and shouldn’t replace proven prevention strategies. Tue, 20 Jan 2026 03:47:11 EST https://www.sciencedaily.com/releases/2026/01/260120000323.htm https://www.sciencedaily.com/releases/2026/01/260118115058.htm While social media continues to circulate claims linking acetaminophen to autism in children, medical experts say those fears distract from a far more serious and proven danger: overdose. Acetaminophen, found in Tylenol and many cold and flu remedies, is one of the leading causes of emergency room visits, hospitalizations, and acute liver failure in the United States. Sun, 18 Jan 2026 12:03:01 EST https://www.sciencedaily.com/releases/2026/01/260118115058.htm https://www.sciencedaily.com/releases/2026/01/260115022808.htm A vitamin A byproduct has been found to quietly disarm the immune system, allowing tumors to evade attack and weakening cancer vaccines. Scientists have now developed a drug that shuts down this pathway, dramatically boosting immune responses and slowing cancer growth in preclinical studies. Fri, 16 Jan 2026 06:06:55 EST https://www.sciencedaily.com/releases/2026/01/260115022808.htm https://www.sciencedaily.com/releases/2026/01/260113220915.htm Despite longstanding guidelines, many dementia patients are still prescribed brain-altering medications that can raise the risk of falls and confusion. A new study shows that while prescribing has decreased overall, people with cognitive impairment remain more likely to receive these drugs. In many cases, there was no documented medical justification. The results suggest that medication safety remains a serious concern in dementia care. Tue, 13 Jan 2026 23:17:46 EST https://www.sciencedaily.com/releases/2026/01/260113220915.htm https://www.sciencedaily.com/releases/2026/01/260112214259.htm MIT engineers have developed a pill that can wirelessly report when it’s been swallowed. Inside the capsule is a biodegradable antenna that sends a signal within minutes of ingestion, then safely dissolves. The system is designed to work with existing medications and could help doctors track adherence for high-risk patients. Researchers hope it will prevent missed doses that can lead to serious health consequences. Tue, 13 Jan 2026 00:55:51 EST https://www.sciencedaily.com/releases/2026/01/260112214259.htm https://www.sciencedaily.com/releases/2026/01/260107225532.htm Long COVID affects an estimated 65 million people worldwide and can damage the brain, heart, blood vessels, and immune system long after infection. Researchers now link symptoms to lingering virus, inflammation, micro-clots, and disrupted energy metabolism. While structured rehab and pacing can improve quality of life, a growing list of experimental treatments—from antivirals and metformin to microbiome therapies and biologics—shows early promise. Clear answers, however, are still limited by small studies and the lack of large, definitive trials. Thu, 08 Jan 2026 19:57:41 EST https://www.sciencedaily.com/releases/2026/01/260107225532.htm https://www.sciencedaily.com/releases/2026/01/260105165817.htm Researchers at USF Health have discovered a new way opioid receptors can work that may lead to safer pain medications. Their findings show that certain experimental compounds can amplify pain relief without intensifying dangerous side effects like suppressed breathing. This research offers a fresh blueprint for designing opioids that last longer, work better, and pose fewer risks. It also opens doors to safer treatments for other brain disorders. Tue, 06 Jan 2026 06:27:34 EST https://www.sciencedaily.com/releases/2026/01/260105165817.htm https://www.sciencedaily.com/releases/2025/12/251227082722.htm A major new review has put hundreds of alternative autism treatments under the microscope—and most didn’t hold up. Scientists analyzed decades of research and found little reliable evidence that popular approaches like probiotics, acupuncture, or music therapy truly work. Alarmingly, safety was often ignored, with many treatments never properly evaluated for side effects. The researchers stress that looking at the full body of evidence matters far more than trusting a single hopeful study. Sun, 28 Dec 2025 01:32:17 EST https://www.sciencedaily.com/releases/2025/12/251227082722.htm https://www.sciencedaily.com/releases/2025/12/251227082716.htm Stanford scientists have uncovered how mRNA COVID-19 vaccines can very rarely trigger heart inflammation in young men — and how that risk might be reduced. They found that the vaccines can spark a two-step immune reaction that floods the body with inflammatory signals, drawing aggressive immune cells into the heart and causing temporary injury. Sat, 27 Dec 2025 10:52:27 EST https://www.sciencedaily.com/releases/2025/12/251227082716.htm https://www.sciencedaily.com/releases/2025/12/251226045322.htm Common diabetes drugs may do more than regulate blood sugar—they could also influence how cancers grow, spread, or slow down. Researchers are now unraveling how these medications affect immune function, inflammation, and tumor biology, with intriguing but still uncertain implications. Fri, 02 Jan 2026 13:01:28 EST https://www.sciencedaily.com/releases/2025/12/251226045322.htm https://www.sciencedaily.com/releases/2025/12/251225235942.htm ADHD stimulants appear to work less by sharpening focus and more by waking up the brain. Brain scans revealed that these medications activate reward and alertness systems, helping children stay interested in tasks they would normally avoid. The drugs even reversed brain patterns linked to sleep deprivation. Researchers say this could complicate ADHD diagnoses if poor sleep is the real underlying problem. Thu, 25 Dec 2025 23:59:42 EST https://www.sciencedaily.com/releases/2025/12/251225235942.htm https://www.sciencedaily.com/releases/2025/12/251222080119.htm New research suggests Alzheimer’s may start far earlier than previously thought, driven by a hidden toxic protein in the brain. Scientists found that an experimental drug, NU-9, blocks this early damage in mice and reduces inflammation linked to disease progression. The treatment was given before symptoms appeared, targeting the disease at its earliest stage. Researchers say this approach could reshape how Alzheimer’s is prevented and treated. Mon, 22 Dec 2025 08:11:02 EST https://www.sciencedaily.com/releases/2025/12/251222080119.htm https://www.sciencedaily.com/releases/2025/12/251221091243.htm Menopause symptoms are common among female endurance athletes and often interfere with training and performance. A survey of women aged 40–60 who train regularly found high rates of sleep problems, exhaustion, anxiety, weight gain, and joint pain. Many athletes said these symptoms made it harder to train effectively or perform at their best. The results highlight a need for greater attention to menopause in active women. Fri, 02 Jan 2026 15:34:01 EST https://www.sciencedaily.com/releases/2025/12/251221091243.htm https://www.sciencedaily.com/releases/2025/12/251217082457.htm A rare tick-borne allergy linked to red meat has now been confirmed as deadly for the first time. A healthy New Jersey man collapsed and died hours after eating beef, with later testing revealing a severe allergic reaction tied to alpha-gal, a sugar spread by Lone Star tick bites. Symptoms often appear hours later, making the condition easy to miss. Researchers warn that growing tick populations could put more people at risk. Wed, 17 Dec 2025 08:24:57 EST https://www.sciencedaily.com/releases/2025/12/251217082457.htm https://www.sciencedaily.com/releases/2025/12/251214100940.htm Back pain is wrapped in persistent myths, but many are far from the truth. From misconceptions about heavy lifting and bed rest to confusion over posture, exercise, and surgery, Dr. Meghan Murphy breaks down what really causes pain and what actually helps. Her insights reveal that everyday habits, movement, and smart prevention often make a bigger difference than people realize. Mon, 15 Dec 2025 01:55:23 EST https://www.sciencedaily.com/releases/2025/12/251214100940.htm https://www.sciencedaily.com/releases/2025/12/251213042249.htm A new analysis suggests that people with type 2 diabetes who use GLP-1 medications like Ozempic, Trulicity or Victoza may be less likely to develop epilepsy than those taking DPP-4 inhibitors. Semaglutide showed the strongest connection to lowered risk. Researchers caution that the findings show an association, not proof of cause and effect. More rigorous long-term studies are needed to understand the link. Sat, 13 Dec 2025 08:52:34 EST https://www.sciencedaily.com/releases/2025/12/251213042249.htm https://www.sciencedaily.com/releases/2025/12/251208052534.htm Deep-brain recordings showed that Mounjaro and Zepbound briefly shut down the craving circuits linked to food noise in a patient with severe obesity. Her obsessive thoughts about food disappeared as the medication quieted the nucleus accumbens, the brain’s reward hub. Mon, 08 Dec 2025 11:37:49 EST https://www.sciencedaily.com/releases/2025/12/251208052534.htm https://www.sciencedaily.com/releases/2025/11/251118220049.htm Researchers discovered that chronic inflammation fundamentally remodels the bone marrow, allowing mutated stem cell clones to quietly gain dominance with age. Reprogrammed stromal cells and interferon-responsive T cells create a self-sustaining inflammatory loop that weakens blood production. Surprisingly, the mutant cells themselves may not be the main instigators. Tue, 18 Nov 2025 22:00:49 EST https://www.sciencedaily.com/releases/2025/11/251118220049.htm https://www.sciencedaily.com/releases/2025/11/251118220041.htm Scientists are uncovering how GLP-1 drugs like Ozempic and Wegovy act on brain regions that control hunger, nausea, pleasure-based eating, and thirst. These discoveries may help create treatments that keep the benefits of weight loss while reducing unwanted side effects. Tue, 18 Nov 2025 22:48:02 EST https://www.sciencedaily.com/releases/2025/11/251118220041.htm https://www.sciencedaily.com/releases/2025/11/251117095639.htm Chronic pain might quietly push people toward developing high blood pressure—and the more widespread the pain, the greater the danger. A massive analysis of over 200,000 adults uncovered strong links between long-lasting pain, depression, inflammation, and rising hypertension risk. Mon, 17 Nov 2025 22:42:19 EST https://www.sciencedaily.com/releases/2025/11/251117095639.htm https://www.sciencedaily.com/releases/2025/11/251116105627.htm GLP-1 drugs like tirzepatide and semaglutide offer powerful weight-loss effects but come with unanswered questions about long-term safety, side effects, and global accessibility. Researchers stress the need for independent studies before these treatments can be fully embraced worldwide. Sun, 16 Nov 2025 22:39:45 EST https://www.sciencedaily.com/releases/2025/11/251116105627.htm https://www.sciencedaily.com/releases/2025/11/251108083910.htm Sertraline (Zoloft) may relieve emotional symptoms of depression and anxiety within two weeks, while physical side effects stabilize later. The research highlights how antidepressants can act on specific symptom networks rather than uniformly across all aspects of depression. Sat, 08 Nov 2025 23:51:50 EST https://www.sciencedaily.com/releases/2025/11/251108083910.htm https://www.sciencedaily.com/releases/2025/11/251106003913.htm Novo Nordisk’s oral semaglutide 25 mg achieved up to 16.6% weight loss in a landmark study, rivaling injectable Wegovy. The pill also improved cardiovascular risk factors and physical activity levels. With a safety profile consistent with existing treatments, experts see it as a breakthrough for patients preferring oral options. Thu, 06 Nov 2025 00:39:13 EST https://www.sciencedaily.com/releases/2025/11/251106003913.htm https://www.sciencedaily.com/releases/2025/10/251030075125.htm Semaglutide appears to safeguard the heart even when patients lose little weight. In a massive international trial, heart attack and stroke risk dropped by 20% regardless of BMI. The benefit seems tied not just to slimming down but to deeper biological effects on inflammation, blood pressure, and vessel health. Researchers say this could expand who qualifies for the drug. Fri, 31 Oct 2025 10:09:30 EDT https://www.sciencedaily.com/releases/2025/10/251030075125.htm https://www.sciencedaily.com/releases/2025/10/251015032316.htm Korean researchers found that low-dose radiation therapy eased knee pain and improved movement in people with mild to moderate osteoarthritis. The treatment, far weaker than cancer radiation, showed real benefits beyond placebo. With no side effects and strong trial results, the approach could provide a middle ground between painkillers and joint surgery. Wed, 15 Oct 2025 10:46:09 EDT https://www.sciencedaily.com/releases/2025/10/251015032316.htm https://www.sciencedaily.com/releases/2025/10/251014014421.htm Endurance exercise may train the immune system as much as the muscles. Older adults with decades of running or cycling had immune cells that functioned better and aged more slowly. Their inflammation levels were lower and their cells resisted fatigue even under stress. The findings point to a direct link between lifelong fitness and healthier immune regulation. Tue, 14 Oct 2025 23:27:02 EDT https://www.sciencedaily.com/releases/2025/10/251014014421.htm https://www.sciencedaily.com/releases/2025/10/251013040343.htm Finasteride, a common hair-loss drug, has long been tied to depression and suicide, but regulators ignored the warnings. Prof. Mayer Brezis’s review exposes global data showing psychiatric harm and a pattern of inaction by Merck and the FDA. Despite its cosmetic use, the drug’s effects on brain chemistry can be devastating. Brezis calls for urgent regulatory reforms and post-marketing studies to protect public health. Mon, 13 Oct 2025 12:48:13 EDT https://www.sciencedaily.com/releases/2025/10/251013040343.htm https://www.sciencedaily.com/releases/2025/10/251011105531.htm Researchers at the University of Barcelona found that combining pemafibrate and telmisartan significantly reduces liver fat and cardiovascular risks in MASLD models. The drug duo works better together than alone, likely due to complementary mechanisms. They also uncovered a new role for the PCK1 protein in fat metabolism. Sun, 12 Oct 2025 09:33:11 EDT https://www.sciencedaily.com/releases/2025/10/251011105531.htm https://www.sciencedaily.com/releases/2025/10/251009033244.htm China’s Guangdong Province is battling its worst-ever chikungunya outbreak, with thousands of infections spreading across major cities and nearby regions. Transmitted by Aedes mosquitoes, the disease underscores how climate change, urbanization, and global travel are fueling mosquito-borne threats. Fri, 10 Oct 2025 09:05:26 EDT https://www.sciencedaily.com/releases/2025/10/251009033244.htm https://www.sciencedaily.com/releases/2025/10/251008030953.htm Drugs taken years—even decades—ago can leave lasting imprints on the gut microbiome, reshaping the community of microbes long after treatment stops. Scientists analyzing over 2,500 Estonian Biobank samples discovered that antibiotics aren’t the only culprits—antidepressants, beta-blockers, and anxiety medications also disrupt gut ecosystems. Some drugs from the same class even have different microbial effects. Thu, 09 Oct 2025 03:44:38 EDT https://www.sciencedaily.com/releases/2025/10/251008030953.htm https://www.sciencedaily.com/releases/2025/10/251008030947.htm A new pill called baxdrostat may offer hope for people whose blood pressure stays high even after taking standard medications. In a recent study, the drug lowered blood pressure and also seemed to protect the kidneys by reducing signs of damage. Doctors say this could help millions of people with chronic kidney disease, a condition that often makes blood pressure harder to control. Wed, 08 Oct 2025 23:01:32 EDT https://www.sciencedaily.com/releases/2025/10/251008030947.htm https://www.sciencedaily.com/releases/2025/10/251006051124.htm Addiction often isn’t about chasing pleasure—it’s about escaping pain. Researchers at Scripps Research have discovered that a tiny brain region called the paraventricular nucleus of the thalamus (PVT) becomes hyperactive when animals learn that alcohol eases the agony of withdrawal. This circuit helps explain why people relapse: their brains learn that alcohol brings relief from stress and anxiety. Mon, 06 Oct 2025 05:11:24 EDT https://www.sciencedaily.com/releases/2025/10/251006051124.htm https://www.sciencedaily.com/releases/2025/10/251003033921.htm A Scandinavian clinical trial has revealed that low-dose aspirin can halve the risk of colon and rectal cancer recurrence in patients with specific genetic mutations. The research, involving over 3,500 patients, is the first randomized study to confirm aspirin’s powerful effect in this context. The findings suggest aspirin could become a widely available, inexpensive precision medicine, reshaping cancer treatment strategies globally. Fri, 03 Oct 2025 03:39:21 EDT https://www.sciencedaily.com/releases/2025/10/251003033921.htm https://www.sciencedaily.com/releases/2025/09/250929054923.htm Morning sickness isn’t just random misery—it’s a biological defense system shaped by evolution to protect the fetus. By linking immune responses to nausea and food aversions, UCLA researchers show these symptoms are signs of a healthy pregnancy. Mon, 29 Sep 2025 22:50:17 EDT https://www.sciencedaily.com/releases/2025/09/250929054923.htm https://www.sciencedaily.com/releases/2025/09/250928095611.htm A groundbreaking international study has shown that a 2-in-1 budesonide-formoterol inhaler is far more effective than the standard salbutamol inhaler in children with mild asthma, cutting attacks by nearly half. Sun, 28 Sep 2025 10:29:35 EDT https://www.sciencedaily.com/releases/2025/09/250928095611.htm https://www.sciencedaily.com/releases/2025/09/250927031221.htm Daily cocoa extract supplements reduced key inflammation markers in older adults, pointing to a role in protecting the heart. The findings reinforce the value of flavanol-rich, plant-based foods for healthier aging. Sat, 27 Sep 2025 12:21:54 EDT https://www.sciencedaily.com/releases/2025/09/250927031221.htm https://www.sciencedaily.com/releases/2025/09/250926035030.htm Scientists have discovered a way to block pain while still allowing the body’s natural healing to take place. Current painkillers like ibuprofen and aspirin often come with harmful side effects because they shut down both pain and inflammation. But this new research identified a single “pain switch” receptor that can be turned off without interfering with inflammation, which actually helps the body recover. Fri, 26 Sep 2025 19:56:30 EDT https://www.sciencedaily.com/releases/2025/09/250926035030.htm https://www.sciencedaily.com/releases/2025/09/250924012248.htm A massive international study has shown that the experimental oral obesity drug orforglipron can help patients shed over 10% of their body weight, with nearly one in five losing 20% or more. Unlike most GLP-1 agonists that require injections, orforglipron comes as a once-daily pill, potentially making weight-loss treatment more accessible. Wed, 24 Sep 2025 23:37:37 EDT https://www.sciencedaily.com/releases/2025/09/250924012248.htm https://www.sciencedaily.com/releases/2025/09/250915202839.htm Preschoolers with ADHD are often given medication right after diagnosis, against medical guidelines that recommend starting with behavioral therapy. Limited access to therapy and physician pressures drive early prescribing, despite risks and reduced effectiveness in young children. Tue, 16 Sep 2025 05:10:52 EDT https://www.sciencedaily.com/releases/2025/09/250915202839.htm https://www.sciencedaily.com/releases/2025/09/250914205832.htm Eye drops combining pilocarpine and diclofenac helped patients read extra lines on vision charts, with effects lasting up to two years. The treatment could revolutionize presbyopia care as a safe, non-surgical alternative to glasses. Mon, 15 Sep 2025 01:23:48 EDT https://www.sciencedaily.com/releases/2025/09/250914205832.htm